Author:
An Yang,Lu Wenyuan,Li Shijia,Lu Xiaoyan,Zhang Yuanyuan,Han Dongcheng,Su Dingyuan,Jia Jiaxin,Yuan Jiaxin,Zhao Binbin,Tu Mengjie,Li Xinyu,Wang Xiaoqing,Fang Na,Ji Shaoping
Abstract
AbstractProstate cancer (PC) is one of the most common cancers in men and becoming the second leading cause of cancer fatalities. At present, the lack of effective strategies for prognosis of PC patients is still a problem to be solved. Therefore, it is significant to identify potential gene signatures for PC patients’ prognosis. Here, we summarized 71 different prognostic gene signatures for PC and concluded 3 strategies for signature construction after extensive investigation. In addition, 14 genes frequently appeared in 71 different gene signatures, which enriched in mitotic and cell cycle. This review provides extensive understanding and integrated analysis of current prognostic signatures of PC, which may help researchers to construct gene signatures of PC and guide future clinical treatment.
Funder
the Program for Science and Technology Development in Henan Province
Innovation Project for College Students of Henan University
the Natural Science Foundation of Henan Province
the Program for Science and Technology Development in Kaifeng City
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Endocrine and Autonomic Systems,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism
Reference92 articles.
1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. Cancer J clin. 2022;72(1):7–33.
2. Perdana NR, Mochtar CA, Umbas R, et al. The risk factors of prostate cancer and its prevention: a literature review. Acta Med Indones. 2016;48(3):228–38.
3. Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467–79.
4. Chipidza FE, Alshalalfa M, Mahal BA, et al. Development and Validation of a Novel TP53 mutation signature that predicts risk of metastasis in primary prostate cancer. Clin Genitourin Cancer. 2021;19(3):246-54.e5.
5. Gu Y, Lin X, Kapoor A, et al. Effective prediction of prostate cancer recurrence through the IQGAP1 network. Cancers. 2021;13(3):430.